These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9446321)

  • 1. [The use of antisense oligonucleotides for modulation of cytokine gene expression].
    Kozlov VA; Sennikov SV
    Vopr Med Khim; 1997; 43(5):308-20. PubMed ID: 9446321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation by cytokine antisense oligonucleotides.
    Lefebvre d'Hellencourt C; Diaw L; Guenounou M
    Eur Cytokine Netw; 1995; 6(1):7-19. PubMed ID: 7795178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of tracer accumulation in malignant tumors: gene expression, gene transfer, and phage display.
    Haberkorn U
    Curr Top Dev Biol; 2005; 70():145-69. PubMed ID: 16338341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines and therapeutic oligonucleotides.
    Hartmann G; Bidlingmaier M; Eigler A; Hacker U; Endres S
    Cytokines Cell Mol Ther; 1997 Dec; 3(4):247-56. PubMed ID: 9740353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antisense oligonucleotides: a new therapeutic approach].
    Guinot P; Temsamani J
    Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of nuclear factor-kappa B p65 antisense oligonucleotides on expression of proinflammatory cytokines in lamina propria mononuclear cells from patients with ulcerative colitis].
    Gan H; Ouyang Q; Chen Y; Liang F
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):268-72. PubMed ID: 12856595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dynamical systems model to simulate the perturbation kinetics of gene expression by antisense oligonucleotides.
    Fennell DA; Cotter FE
    J Theor Biol; 2001 Mar; 209(1):103-12. PubMed ID: 11237574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disposition (ADME) of antisense oligonucleotides.
    Dvorchik BH
    Curr Opin Mol Ther; 2000 Jun; 2(3):253-7. PubMed ID: 11249618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT1 antisense oligonucleotides attenuate the proinflammatory cytokine release of alveolar macrophages in bleomycin-induced fibrosis.
    Fan X; Wang Z
    Cell Mol Immunol; 2005 Jun; 2(3):211-7. PubMed ID: 16212889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of TGF-beta by antisense oligonucleotides modulates expression of VEGF and increases angiogenic potential in isolated fibroblasts from radiated skin.
    Riedel K; Koellensperger E; Ryssel H; Riedel F; Goessler UR; Germann G; Kremer T
    Int J Mol Med; 2008 Oct; 22(4):473-80. PubMed ID: 18813854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of antisense to study gene expression. Introduction.
    Erickson RP
    Methods; 1999 Jul; 18(3):241-3. PubMed ID: 10454981
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
    Mahato RI; Cheng K; Guntaka RV
    Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense effects in the cell nucleus: modification of splicing.
    Kole R; Sazani P
    Curr Opin Mol Ther; 2001 Jun; 3(3):229-34. PubMed ID: 11497345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of macrophage proinflammatory functions by cytokine-expressing Salmonella vectors.
    Fernandez-Cabezudo MJ; Mechkarska M; Azimullah S; al-Ramadi BK
    Clin Immunol; 2009 Jan; 130(1):51-60. PubMed ID: 18835224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotides: from design to therapeutic application.
    Chan JH; Lim S; Wong WS
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):533-40. PubMed ID: 16700890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense therapy for cancer.
    Gleave ME; Monia BP
    Nat Rev Cancer; 2005 Jun; 5(6):468-79. PubMed ID: 15905854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAi: a novel antisense technology and its therapeutic potential.
    Dallas A; Vlassov AV
    Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis.
    Uchio K; Graham M; Dean NM; Rosenbaum J; Desmoulière A
    Wound Repair Regen; 2004; 12(1):60-6. PubMed ID: 14974966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense raf oligodeoxyribonucleotide is protected by liposomal encapsulation and inhibits Raf-1 protein expression in vitro and in vivo: implication for gene therapy of radioresistant cancer.
    Gokhale PC; Soldatenkov V; Wang FH; Rahman A; Dritschilo A; Kasid U
    Gene Ther; 1997 Dec; 4(12):1289-99. PubMed ID: 9472552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.